
A recent multicenter study examined the effectiveness of Magnetic Resonance-Guided Laser Interstitial Thermal Therapy (MRgLITT) as an alternative to surgery for drug-resistant mesial temporal lobe epilepsy (mTLE). The study, spanning 2012 to 2018 and involving 268 patients across 11 centers, found that 55.8% achieved seizure freedom at 1 year, dropping to 49.3% at the last follow-up (median 47 months). Preoperative focal to bilateral tonic-clonic seizures increased the risk of recurrence. For those with recurrence, 66.7% became seizure-free after subsequent surgery, with 50% achieving freedom after repeat MRgLITT. While MRgLITT showed lower seizure freedom rates than surgery, the study underscores its viability and suggests Anterior Temporal Lobectomy (ATL) remains a safe option for MRgLITT failures.
Like
Save
Share